A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/101
A61K 51/04 (2006.01) A61N 5/10 (2006.01)
Patent
CA 2003326
The invention concerns a method for suppressing bone marrow which comprises administering to a mammal at least one bone marrow suppressing complex of a radionuclide selected from Samarium-153, Gadolinium-159, Holmium-166 and Yttrium-90 and at least one macrocyclic aminophosphonic acid ligand containing the 1,4,7,10-tetraazacyclododecane moiety, or a physiologically acceptable salt thereof. Suitable compositions for use in this method are also provided.
L'invention porte sur une méthode visant à éliminer la moelle osseuse par administration à un mammifère d'une composition, cette composition comprenant au moins un radionucléide éliminant la moelle osseuse choisi parmi les suivants : samarium 153, gadolinium 159, holmium 166 et yttrium 90 et au moins un ligand de l'acide aminophosphonique macrocyclique comprenant la variété 1,4,7,10 - tétra-azacyclododécane, ou encore un sel de ce genre aux caractéristiques physiologiques acceptables. On dévoile également des compositions adéquates pour l'emploi de la méthode.
Garlich Joseph R.
Mcmillan Kenneth
Simon Jaime
Wilson David A.
Smart & Biggar
The Dow Chemical Company
LandOfFree
Bone marrow suppressing agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bone marrow suppressing agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bone marrow suppressing agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1829562